PDF Cover

Hernia Mesh Devices Market

The market for Hernia Mesh Devices was estimated at $5.8 billion in 2025; it is anticipated to increase to $8.2 billion by 2030, with projections indicating growth to around $11.8 billion by 2035.

Report ID:DS1801100
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Hernia Mesh Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Hernia Mesh Devices Market Outlook

Revenue, 2025

$5.8B

Forecast, 2035

$11.8B

CAGR, 2026 - 2035

7.4%

The Hernia Mesh Devices industry revenue is expected to be around $5.8 billion in 2026 and expected to showcase growth with 7.4% CAGR between 2026 and 2035. The market for hernia meshes is destined to grow, its growth driven by the expanding need for hernia management world wide, together with factors including an aging global population and an increase in the number of minimally invasive surgeries. In the medical sector, hospitals and outpatient surgical centres collectively create 78.9% of the demand from end users. This highlights the key influence that hospitals and clinics have on the purchasing decisions, the implementation of clinical guidelines and the preferences of surgeons in this field. Due to their widespread availability and clinical and cost advantages, the $4.28 billion synthetic hernia market continues to lead the way. The devices are used for both open and laparoscopic procedures. New products with better biocompatibility and fixation are being continually developed.

Hernia repair devices involve a surgical mesh used to repair hernias. These are most often synthetic or composite materials with varying characteristics including flexibility and the ability to be absorbed by the body. The implants are customised as per anatomical and surgical requirements. Procedures using these products are primarily for inguinal hernia repair, ventral hernia repair, incisional hernia repair and umbilical hernia repair. They are employed in open, laparoscopic hernia repair and increasingly robotic assisted techniques in hospitals and ambulatory surgery centers. The centers prioritise the reduction of hernia recurrence rates and recovery times. A surge in outpatient hernia procedures, together with emerging next generation lightweight and barrier coated hernia meshes aiming to limit the experience of post operative pain and reduce occurrences of adhesions, are causing a growth in the hernia repair devices market. Higher sales of shaped and three dimensional meshes which ease placement times and increased concentration on long term effects and the safety of the product are also driving the sector. The end result is the growing uptake of advanced mesh repair technologies for hernias in high volume operating theatres.

Hernia Mesh Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Hernia Mesh Devices Market Outlook

Market Key Insights

  • The Hernia Mesh Devices market is projected to grow from $5.8 billion in 2025 to $11.8 billion in 2035. This represents a CAGR of 7.4%, reflecting rising demand across Hernia Repair Surgery, Complex Hernia Treatment, and Post-Surgical Wound Treatment.

  • The market is dominated by a number of large corporations including Ethicon, Medtronic and Becton Dickinson, these companies have considerable influence on the markets competitive landscape.

  • The US and Germany are set to be leading markets in the hernia mesh devices industry and are projected to see growth rates ranging between 4.8 and 7.1% annually from 2025 to 2030.

  • The countries that are expected to grow most are China, South Korea and India, with annual growth rates of between 8.5% and 10.2%.

  • By 2030 the growth of the hernia mesh market is predicted to be aided by increasing technological innovation of around $626m.

  • The hernia mesh devices industry is forecast to see growth of $6 billion in sales between 2025 and 2035, with the makers targeting specialist clinics and ambulatory surgical centres for sales of their products in this application region.

  • Growing numbers of hernia cases alongside the improvements in the surgical repair technology is likely to see hernia mesh product sales increase by 104% between 2035 and 2025.

hernia mesh devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Hernia Mesh Devices - Country Share Analysis

Opportunities in the Hernia Mesh Devices

In Western Europe the number of patients suffering from inguinal hernias is also increasing, largely due to the regions rapidly ageing population. However, hernia repair devices which cater for elderly patients are still relatively rare. A trend in hospitals is towards the use of lighter Hernia Meshes which help in reducing chronic pain and early mobilisation for patients who have undergone minimally invasive hernia surgery. Healthcare providers combining laparoscopic surgery programmes, geriatric focused design and patient outcomes data can access extra payments. The advanced synthetic meshes will enjoy the strongest volume growth in key Western European markets.

Growth Opportunities in North America and Europe

The market for hernia mesh devices in North America is driven primarily by a high volume of operations to treat elective and emergency hernia conditions. Surgical practices are increasingly shifting towards the use of laparoscopic surgical techniques, which are reimbursed well, with the result that sales are also being driven by this region. Those vendors who are focused on growth can expect the majority of their sales to come from ambulatory surgical centres. While complex ventral hernia and recurrent inguinal hernia cases are typically carried out in hospitals, the trend of less complex cases being treated in ambulatory surgery centres is putting ASCs in a competitive position with regards to the cost of surgical mesh, package deals for treatment and the implementation of fast recovery programmes. The competitive landscape in this field is defined by established large scale producers who manufacture globally and smaller agile regional companies. These regional companies differentiate their products with the use of lighter weight polypropylene mesh, implants that are shaped to fit the anatomy of a patient, and a method of securing the mesh with the patients anatomy in mind. This is beneficial for those undergoing outpatient treatment. Potential opportunities include teaming up with ASC networks to supply standardised hernia repair packs, co developing training courses with surgeons to make them proficient in certain procedures and targeting high end tissue repair products at complex surgeries in major hospitals. Additionally, it may be worthwhile to develop cost reduced options for ASCs and private clinics which carry out high volumes of these operations.
Across Europe, the hernia mesh devices market is being driven by strict clinical guidelines, public health service measures to control costs and the increasing preference for surgical hernia repair involving a laparoscope, hospitals offering teaching and which are public remaining the key users in relation to formulary access and standardising treatments. Centres specialising in hernia cases and the clinics which undertake a large number of hernia surgeries are the key figures who shape public perception towards advanced synthetic and biological hernia mesh materials, hybrid synthetic and biological mesh and also the technologies that ensure fixation. Due to the competitive marketplace where international corporations and domestic companies in this sector compete with one another, demand for devices that treat hernias has resulted in price sensitive public tender bids. Consequently, manufacturers are working to create hernia mesh products which will reduce the rate of recurrence and demonstrate the effectiveness of their devices over a long period of time. Companies could secure their market share by developing clinical data which can be used in forming treatment guidelines, adapting the range of hernia mesh devices to national health service reimbursement levels and offering support packages to hospitals to allow them to implement minimal invasive hernia repair procedures.

Market Dynamics and Supply Chain

01

Driver: Rising Incidence of Hernias Combined with Demand for Minimally Invasive Surgeries

The global increase in hernia cases is also a primary growth factor driving the hernia mesh devices market. Lifestyle changes, aging populations, obesity, and post-operative complications contribute to the growing prevalence of inguinal, ventral, and incisional hernias. Hospitals and surgical centers are also witnessing higher patient inflow, boosting demand for reliable hernia repair solutions. Simultaneously, the shift toward minimally invasive procedures such as laparoscopic devices and robotic-assisted surgeries is also accelerating market growth. These approaches require advanced mesh devices that are also flexible, lightweight, and easy to implant through small incisions. Surgeons favor meshes with superior biocompatibility and reduced adhesion risk to ensure faster recovery, lower recurrence, and fewer post-operative complications. Companies like Johnson & Johnson (Ethicon), Medtronic, and B. Braun are also responding with innovative composite and self-fixating meshes tailored for minimally invasive platforms, driving adoption in advanced healthcare facilities.
The development of advanced biologic and composite meshes is also a significant market driver. These meshes offer enhanced tissue integration, reduced infection risk, and improved flexibility for complex hernia repairs. Innovations in resorbable polymers and hybrid coatings are also enabling surgeons to treat high-risk patients more effectively while minimizing post-operative complications. The trend toward patient-specific, customizable mesh solutions is also also gaining momentum, with leading players focusing on research and development to enhance surgical outcomes and broaden clinical adoption across tertiary care hospitals.
02

Restraint: High regulatory barriers and litigation risks slow product approvals and increase costs

The hernia mesh devices market faces significant regulatory scrutiny and ongoing litigation related to implant safety and long‑term complications. Stricter approval pathways in the US and EU increase development timelines and require costly clinical evidence, delaying new product launches. High‑profile legal cases have also raised procurement caution among healthcare providers, suppressing demand for certain mesh types and pressuring pricing, which in turn constrains revenue growth and investor confidence.
03

Opportunity: Premium Hernia Mesh Devices for complex abdominal wall reconstruction in advanced North American and European hospitals and Expanding adoption of Hernia Mesh Devices in ambulatory surgical centers across India and Southeast Asia

Leading centres in Europe and North America for hospitals are giving priority to the new of hernia mesh which has been developed to help patients suffering from complex hernia conditions. Yet the more expensive products in this field are still largely unknown in many regions outside of a few major medical research facilities. A growing need for durability over a long period coupled with fewer surgical complications has led to the increased demand for next generation hernia meshes. Biological meshes, which are especially suited to complex hernia repair procedures, have been in greater demand. The biological sector is projected to expand more quickly than the general surgical mesh market, thus it will rise from $1.48 billion in 2025 to $2.31 billion in 2030.
Growing in India and Southeast Asia are the volumes of procedures that involve the elective repair of hernias as more of the region has health care infrastructure and health insurance. Nevertheless, the usage of the more sophisticateds of hernia repair tools, especially hernia mesh equipment, in outpatient surgery clinics remains relatively low. Firms can secure market share by launching cost effective synthetic mesh hernia product lines and surgical training packages for endoscopic hernia repair. In this regional market the fastest growth will be experienced by synthetic mesh products, this in turn will drive the global synthetic meshes market from $4.28 billion in 2025 to $5.92 billion by 2030.
04

Challenge: Patient safety concerns and surgeon preference hinder adoption of advanced meshes

Persistent concerns about mesh‑related complications such as infection, chronic pain, or adhesion formation reduce surgeon willingness to adopt newer or premium products. In many regions, practitioners prefer traditional repair techniques or low‑cost meshes to avoid post‑operative risks, especially in complex cases. This behavior dampens uptake of biologic and hybrid meshes designed for demanding hernia repairs, limiting market expansion and slowing revenue growth for innovative device manufacturers.

Supply Chain Landscape

1

Surgical Mesh Materials

CovestroDuPontDSM
2

Hernia Mesh Devices

MedtronicEthiconBecton Dickinson
3

Hernia Repair Distribution

Cardinal HealthOwens & MinorMcKesson
4

Clinical End-Use

HospitalsAmbulatory Surgical CentersSpecialty Clinics
Hernia Mesh Devices - Supply Chain

Use Cases of Hernia Mesh Devices in Repair Surgery & Post-Surgical Wound Treatment

Hernia Repair Surgery : Hernia mesh devices are predominantly used in hernia repair surgeries by general surgeons and surgical teams to reinforce weakened abdominal walls and reduce recurrence rates. Synthetic and composite meshes are the most common types, offering high tensile strength, biocompatibility, and ease of implantation. Leading companies such as Johnson & Johnson (Ethicon), Medtronic, and B. Braun dominate this segment, providing advanced meshes with superior integration and minimal post-operative complications, strengthening their position in hospitals and surgical centers worldwide.
Complex Hernia Treatment : In complex hernia treatment, specialized meshes like biologic and hybrid meshes are primarily utilized by experienced surgeons in tertiary hospitals to manage large, recurrent, or contaminated hernia cases. These meshes provide enhanced tissue regeneration, infection resistance, and flexibility, ensuring successful repair outcomes. Key players including Medtronic, C.R. Bard, and Johnson & Johnson (Ethicon) lead this market with innovative products, robust clinical support, and widespread adoption in advanced surgical facilities globally.
Post-Surgical Wound Treatment : Hernia mesh devices are also applied in post-surgical wound treatment to support tissue healing and prevent complications such as hernia recurrence or dehiscence. Surgeons and wound care specialists use resorbable or coated meshes that minimize inflammation and integrate well with surrounding tissues. Major providers like Johnson & Johnson (Ethicon), Medtronic, and B. Braun supply advanced meshes with improved biocompatibility and patient safety, reinforcing their strong presence in both hospital and outpatient surgical settings.

Recent Developments

Recent developments in Surgical Mesh show strong momentum in product innovation and biocompatible mesh materials, with major players launching lightweight, absorbable, and antimicrobial mesh solutions to improve patient outcomes and reduce complications in hernia repair surgery. Medtronic and Ethicon are expanding biologic and composite mesh portfolios while antimicrobial and hybrid devices gain traction globally. A key market trend is the shift toward minimally invasive and robotic‑compatible mesh solutions that enhance procedural precision, shorten recovery times, and support broader clinical adoption.

April 2025 : BD (Becton, Dickinson and Company) received U.S. FDA 510(k) clearance and launched the Phasix ST Umbilical Hernia Patch, the first fully bioabsorbable mesh tailored for umbilical hernia repair, expanding its Phasix portfolio and offering surgeons a resorbable alternative to permanent mesh.
February 2025 : W. L. Gore & Associates introduced GORE SYNECOR Preperitoneal Biomaterial across Europe, the Middle East, and South Africa, providing a hybrid mesh option designed for ease of use in minimally invasive and open hernia repairs.
April 2024 : Ethicon (Johnson & Johnson) launched its next‑generation PROCEED Ventral Patch for small ventral hernia repairs, enhancing its hernia mesh portfolio and reinforcing its leadership in composite mesh solutions.

Impact of Industry Transitions on the Hernia Mesh Devices Market

As a core segment of the Medical Device industry, the Hernia Mesh Devices market develops in line with broader industry shifts. Over recent years, transitions such as Increasing Technological Innovations and Digitalization and Minimally Invasive Integration have redefined priorities across the Medical Device sector, influencing how the Hernia Mesh Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Increasing Technological Innovations

The main growth driver in the hernia mesh industry is currently technological advancements. This is because mesh implants that are biocompatible, have a three dimensional mesh structure and are self fixating all increase surgical efficiency, reduce the number of complications and improve the patients long term health. With surgeons increasingly favouring minimally invasive techniques for hernia repair which feature greater ease of placement along with durable integration with surrounding tissue, sales of advanced hernia repair meshes are increasing quickly. The shift is not only just altering product lines and research priorities, it is also expected to result in extra business of around $626 million by 2030, showing its significance to the manufacturers involved. Organisations that successfully bring to market hernia mesh products which are technologically advanced and which have clinical advantages will be in a strong position to gain market share, to charge higher prices and to form stronger ties with hospitals.
02

Digitalization and Minimally Invasive Integration

The integration of hernia mesh devices with minimally invasive surgical techniques, such as laparoscopic and robotic-assisted procedures, represents a key industry transition. Advanced meshes designed for easy deployment through trocars or ports improve procedural efficiency, reduce patient recovery time, and minimize post-operative complications. This trend has accelerated adoption in hospitals and outpatient surgery centers, prompting companies like C.R. Bard and B. Braun to develop ergonomic, pre-shaped, and coated meshes tailored for robotic-assisted repairs. The transition has also encouraged cross-industry collaboration with surgical robotics manufacturers and imaging software providers, enhancing precision, training, and patient safety in hernia management.